Related Experiment Video
Updated: Jan 14, 2026

09:42
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
Published on: June 7, 2017
12.0K
Unveiling dry eye with autoimmune features (DEAF): insights from a prospective longitudinal study
Hao Li1, Qin Zhang2, Zhongcheng Shen3
1Department of Rheumatology and Immunology, Peking University People's Hospital, No. 11 Xizhimen South Street, Beijing, 100044, China.
Clinical Rheumatology
|January 13, 2026
Summary
Dry eye with autoimmune features (DEAF) patients show distinct clinical and serological markers, potentially indicating a pre-stage of Sjögren's disease or other autoimmune conditions. Early identification of DEAF may improve diagnosis and treatment for connective tissue diseases.
Area of Science:
- Ophthalmology
- Immunology
- Rheumatology
Background:
- Dry eye disease (DED) is common, often co-occurring with autoimmune conditions like Sjögren's disease (SjD).
- Some DED patients exhibit autoimmune signs but don't meet criteria for diagnosed connective tissue diseases (CTDs).
- This necessitates defining a distinct group: dry eye with autoimmune features (DEAF).
Purpose of the Study:
- To describe and propose the novel concept of "dry eye with autoimmune features (DEAF)".
- To identify distinct clinical and serological characteristics of DEAF patients.
- To evaluate the potential progression of DEAF to CTDs.
Main Methods:
- Prospective longitudinal study in an ophthalmology clinic.
- Collected data on medical history, ocular exams, and serology.
- Utilized heatmap, PCA, and PLS-DA for patient clustering into dry eye, DEAF, and SjD groups.
Main Results:
- DEAF patients exhibited higher DEQ-5/SPEED scores and lower IgG than SjD patients.
- Nasal conjunctival OSS levels were higher in DEAF and SjD groups.
- Anti-α-fodrin antibody levels were elevated in DEAF patients.
- 39.3% of DEAF patients developed CTDs, predominantly SjD, within 3 years.
Conclusions:
- DEAF patients possess unique clinical and serological profiles.
- DEAF may represent an early phase in the autoimmune disease spectrum.
- Identifying DEAF can aid early diagnosis and management of potential CTDs.

